These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 468898)

  • 81. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
    Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
    Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of perfluorochemicals on BCNU chemotherapy: preliminary study in a rat brain tumor model.
    Kokunai T; Kuwamura K
    Surg Neurol; 1982 Oct; 18(4):258-61. PubMed ID: 7179085
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Gadjeva V; Lazarova G; Zheleva A
    Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
    Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [THE INFLUENCE OF PROGENITOR NEURO- CELLS SUPERNATANT ON THE LYMPHO- CYTES CYTOTOXIC FUNCTION IN RATS WITH GLIOMA].
    Liubich LD; Lisyany NI
    Fiziol Zh (1994); 2015; 61(4):63-70. PubMed ID: 26552307
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of the properties of metabolites of CCNU.
    Wheeler GP; Johnston TP; Bowdon BJ; McCaleb GS; Hill DL; Montgomery JA
    Biochem Pharmacol; 1977 Dec; 26(24):2331-6. PubMed ID: 145865
    [No Abstract]   [Full Text] [Related]  

  • 90. The contemporary role of chemotherapy in the treatment of malignant brain tumor.
    Walker MD
    Clin Neurosurg; 1978; 25():388-96. PubMed ID: 710004
    [No Abstract]   [Full Text] [Related]  

  • 91. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
    Buge A; Poisson M; Pouillart P
    Rev Neurol (Paris); 1978 May; 134(5):369-77. PubMed ID: 364592
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of early treatment with methyl-CCNU on the lymphoid organs and the humoral immune response in chickens.
    Zimber A; Perk K
    Poult Sci; 1979 Jan; 58(1):162-72. PubMed ID: 471882
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Karyometric, cytophotometric and histoenzymatic studies on neuroglia of rats treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU/lomoustine).
    Szczech J
    Exp Pathol; 1986; 30(4):221-31. PubMed ID: 2949995
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A simple method for producing different growth fractions in vitro for use in anti-cancer drug studies.
    Barranco SC; Bolton WE; Novak JK
    Cell Tissue Kinet; 1979 Jan; 12(1):11-6. PubMed ID: 570456
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The toxicological study of CCNU controlled release film in vivo.
    Sun Y; Xu L; Zhang Q; Zhou H; Wang F
    Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):593-8. PubMed ID: 15974185
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The proliferative state of clonogenic cells in the Lewis lung tumour after treatment with cytotoxic agents.
    Bateman AE; Steel GG
    Cell Tissue Kinet; 1978 Sep; 11(5):445-54. PubMed ID: 569015
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.
    Look T; Puca E; Bühler M; Kirschenbaum D; De Luca R; Stucchi R; Ravazza D; Di Nitto C; Roth P; Katzenelenbogen Y; Weiner A; Rindlisbacher L; Becher B; Amit I; Weller M; Neri D; Hemmerle T; Weiss T
    Sci Transl Med; 2023 May; 15(697):eadf2281. PubMed ID: 37224228
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Effects of iron ion additional introduction in radiation therapy of tumor-bearing animals].
    Ivanov SD; Semenov AL; Mikhelson VM; Kovan'ko EG; Iamshanov VA
    Radiats Biol Radioecol; 2013; 53(3):296-303. PubMed ID: 24450211
    [TBL] [Abstract][Full Text] [Related]  

  • 100. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.
    Amarasingh S; Macleod MR; Whittle IR
    J Neurooncol; 2009 Jan; 91(2):117-25. PubMed ID: 18813876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.